| Log in

Daiichi Completes Ranbaxy Open Offer; Singhs Yet To Sell

17 October, 2008

Japanese pharma major Daiichi Sankyo has completed the purchase of 20% stake in Ranbaxy Laboratries through the public offer. The stake has been purchased for Rs 6,818 crore at a price of Rs 737 per share.

However, the deal between the promoters (the Singh family of Ranbaxy) and Daiichi Sankyo is yet to be concluded since the Singhs are looking at a tax-efficient transaction route. The sale of 34.82% stake of the Singhs would be worth Rs 9,576 crore which if it’s done via an off-market transaction, it would result in capital gains tax (10%) and surcharge liabilities of close to Rs 1,000 crore.

If the transaction is done via bulk deal on bourses, then it would attract only securities transaction tax of 0.125% in addition to broker’s fee and 12.5% service tax on the broker’s fee. This would have meant a tax of few crores of rupees.

But market regulator Securities and Exchange Board of India (SEBI) has refused the stake sale of promoter’s holding through bulk deals on the bourses.

Daiichi Sankyo’s acquisition of Ranbaxy involved acquisition of stake in the latter through combination of four steps – (i) purchase of shares held by the Singh family, who have a 34.82% stake, (ii) preferential allotment of equity shares, (iii) subscription of warrants, and (iv) open offer for 20% stake, mandatory under SEBI rules. The final step of the deal is done, but the first step now seems to be in a limbo.

Life Insurance Corp of India (LIC), which holds a 15% stake in Ranbaxy, has sold off a 6.91% stake in the public offer. Ranbaxy’s share price has closed at Rs 256 today, which is much lower than its offer price of Rs 737.


View Comments
Daiichi Sankyo Buys 52.5% In Ranbaxy; Singhs Sell 20% Via Off-Market

Daiichi Sankyo Buys 52.5% In Ranbaxy; Singhs Sell 20% Via Off-Market

TEAM VCC 9 years ago
Japanese pharma major Daiichi Sankyo has acquired a total of 52.5% stake in...
Daiichi Sankyo Completes Acquisition of Ranbaxy Labs

Daiichi Sankyo Completes Acquisition of Ranbaxy Labs

TEAM VCC 9 years ago
The Singh family has sold off its remaining stake in Ranbaxy Laboratories Ltd,...
Sun Pharma to buy Ranbaxy in $3.2B all-stock deal

Sun Pharma to buy Ranbaxy in $3.2B all-stock deal

TEAM VCC 3 years ago
Sun Pharmaceutical Industries Ltd, the country’s top drugmaker by market cap,...
1 Comment
s.ramabadran . 5 years ago

the stand of Sebi or IT dept cannot change depending on the value of the transaction.

Daiichi Completes Ranbaxy Open Offer; Singhs Yet To Sell

Powered by WordPress.com VIP